Lung Cancer
News and reporting on lung cancer.
Tencent Invests $30M in Early Cancer Detection Firm Insighta
Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.
Burning Rock, Dizal Get Chinese Approval for Lung Cancer CDx
The test, approved by Chinese regulators in early 2022, is designed for the detection of multiple mutation statuses for nine genes.
Kairos Pharma, PreCheck Health Services to Develop CDx for Prostate, Lung Cancer Drug
PreCheck will help the biopharma firm confirm and validate biomarkers previously identified in early-phase trials for companion diagnostic use.
Researchers analyzed molecular and particulate matter exposure data on nearly 9,000 NSCLC patients in France and confirmed a link reported by UK scientists in 2022.
Local Coverage Determinations Roundup: Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.